(Q46743802)

English

Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

author name string

Yochai Birnbaum

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

Yu Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

Yumei Ye

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

Ramanna Merla

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

Jose R Perez-Polo

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

Barry F Uretsky

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

Journal of Cardiovascular Pharmacology and Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

13

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

72-79

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

The pleiotropic effects of statins.

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with p

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Reduction of infarct size by short-term pretreatment with atorvastatin

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Pretreatment with statins enhances myocardial protection during coronary revascularization

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation.

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxide

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Neuroprotection mediated by changes in the endothelial actin cytoskeleton.

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study

1 reference

https://api.crossref.org/works/10.1177%2F1074248407312839

21 January 2018

Identifiers

10.1177/1074248407312839

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18287593

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46743802&oldid=879695670"